Pierrakos C, Vincent J-L: Sepsis biomarkers: a review. Crit Care 2010, 14: R15. 10.1186/cc8872
Article
PubMed
PubMed Central
Google Scholar
Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A: Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003, 31: 1737-1741. 10.1097/01.CCM.0000063440.19188.ED
Article
PubMed
CAS
Google Scholar
Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret G-Y: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006, 34: 1996-2003. 10.1097/01.CCM.0000226413.54364.36
Article
PubMed
CAS
Google Scholar
Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R: Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 2000, 26: S148-S152. 10.1007/s001340051134
Article
PubMed
Google Scholar
Abidi K, Khoudri I, Belayachi J, Madani N, Zekraoui A, Zeggwagh AA, Abouqal R: Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. Crit Care 2008, 12: R59. 10.1186/cc6883
Article
PubMed
PubMed Central
Google Scholar
Abidi K, Belayachi J, Derras Y, Khayari ME, Dendane T, Madani N, Khoudri I, Zeggwagh AA, Abouqal R: Eosinopenia, an early marker of increased mortality in critically ill medical patients. Intensive Care Med 2011, 37: 1136-1142. 10.1007/s00134-011-2170-z
Article
PubMed
Google Scholar
Antonatos D, Patsilinakos S, Spanodimos S, Korkonikitas P, Tsigas D: Cell-free DNA levels as a prognostic marker in acute myocardial infarction. Ann N Y Acad Sci 2006, 1075: 278-281. 10.1196/annals.1368.037
Article
PubMed
CAS
Google Scholar
Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R: DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001, 61: 1659-1665.
PubMed
CAS
Google Scholar
Macher H, Egea-Guerrero JJ, Revuelto-Rey J, Gordillo-Escobar E, Enamorado-Enamorado J, Boza A, Rodriguez A, Molinero P, Guerrero JM, Dominguez-Roldán JM, Murillo-Cabezas F, Rubio A: Role of early cell-free DNA levels decrease as a predictive marker of fatal outcome after severe traumatic brain injury. Clin Chim Acta 2012, 414: 12-17.
Article
PubMed
CAS
Google Scholar
Choi J-J, Reich CF 3rd, Pisetsky DS: Release of DNA from dead and dying lymphocyte and monocyte cell lines in vitro. Scand J Immunol 2004, 60: 159-166. 10.1111/j.0300-9475.2004.01470.x
Article
PubMed
CAS
Google Scholar
Rhodes A, Wort SJ, Thomas H, Collinson P, Bennett ED: Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care 2006, 10: R60. 10.1186/cc4894
Article
PubMed
PubMed Central
Google Scholar
Saukkonen K, Lakkisto P, Varpula M, Varpula T, Voipio-Pulkki L-M, Pettilä V, Pulkki K: Association of cell-free plasma DNA with hospital mortality and organ dysfunction in intensive care unit patients. Intensive Care Med 2007, 33: 1624-1627. 10.1007/s00134-007-0686-z
Article
PubMed
CAS
Google Scholar
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101: 1644-1655. 10.1378/chest.101.6.1644
Article
PubMed
CAS
Google Scholar
Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut J-F, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent J-L, International Surviving Sepsis Campaign Guidelines Committee, American Association of Critical-Care Nurses, American College of Chest Physicians, American College of Emergency Physicians, Canadian Critical Care Society, European Society of Clinical Microbiology and Infectious Diseases, et al.: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36: 296-327. 10.1097/01.CCM.0000298158.12101.41
Article
PubMed
Google Scholar
Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985, 13: 818-829. 10.1097/00003246-198510000-00009
Article
PubMed
CAS
Google Scholar
Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22: 707-710. 10.1007/BF01709751
Article
PubMed
CAS
Google Scholar
DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44: 837-845. 10.2307/2531595
Article
PubMed
CAS
Google Scholar
Wacker C, Prkno A, Brunkhorst FM, Schlattmann P: Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013, 13: 426-435. 10.1016/S1473-3099(12)70323-7
Article
PubMed
CAS
Google Scholar
Gibot S, Béné MC, Noel R, Massin F, Guy J, Cravoisy A, Barraud D, De Carvalho BM, Quenot J-P, Bollaert P-E, Faure G, Charles P-E: Combination biomarkers to diagnose sepsis in the critically ill patient. Am J Respir Crit Care Med 2012, 186: 65-71. 10.1164/rccm.201201-0037OC
Article
PubMed
CAS
Google Scholar
Shaaban H, Daniel S, Sison R, Slim J, Perez G: Eosinopenia: Is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital? J Crit Care 2010, 25: 570-575. 10.1016/j.jcrc.2010.03.002
Article
PubMed
CAS
Google Scholar
Claeys R, Vinken S, Spapen H, Ver Elst K, Decochez K, Huyghens L, Gorus FK: Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002, 30: 757-762. 10.1097/00003246-200204000-00006
Article
PubMed
CAS
Google Scholar
Pettilä V, Hynninen M, Takkunen O, Kuusela P, Valtonen M: Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med 2002, 28: 1220-1225. 10.1007/s00134-002-1416-1
Article
PubMed
Google Scholar
Karlsson S, Heikkinen M, Pettilä V, Alila S, Väisänen S, Pulkki K, Kolho E, Ruokonen E, Finnsepsis Study Group: Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Crit Care 2010, 14: R205. 10.1186/cc9327
Article
PubMed
PubMed Central
Google Scholar
Dahaba AA, Hagara B, Fall A, Rehak PH, List WF, Metzler H: Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth 2006, 97: 503-508. 10.1093/bja/ael181
Article
PubMed
CAS
Google Scholar
Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M: Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006, 34: 2596-2602. 10.1097/01.CCM.0000239116.01855.61
Article
PubMed
CAS
Google Scholar
Schuetz P, Maurer P, Punjabi V, Desai A, Amin DN, Gluck E: Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. Crit Care 2013, 17: R115. 10.1186/cc12787
Article
PubMed
PubMed Central
Google Scholar
Clec’h C, Fosse J-P, Karoubi P, Vincent F, Chouahi I, Hamza L, Cupa M, Cohen Y: Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006, 34: 102-107. 10.1097/01.CCM.0000195012.54682.F3
Article
PubMed
Google Scholar
Jekarl DW, Lee S-Y, Lee J, Park Y-J, Kim Y, Park JH, Wee JH, Choi SP: Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis. Diagn Microbiol Infect Dis 2013, 75: 342-347. 10.1016/j.diagmicrobio.2012.12.011
Article
PubMed
CAS
Google Scholar
Giamarellos-Bourboulis EJ, Mega A, Grecka P, Scarpa N, Koratzanis G, Thomopoulos G, Giamarellou H: Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med 2002, 28: 1351-1356. 10.1007/s00134-002-1398-z
Article
PubMed
Google Scholar
Nobre V, Harbarth S, Graf J-D, Rohner P, Pugin J: Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008, 177: 498-505. 10.1164/rccm.200708-1238OC
Article
PubMed
CAS
Google Scholar
Tsalik EL, Jaggers LB, Glickman SW, Langley RJ, van Velkinburgh JC, Park LP, Fowler VG, Cairns CB, Kingsmore SF, Woods CW: Discriminative value of inflammatory biomarkers for suspected sepsis. J Emerg Med 2012, 43: 97-106. 10.1016/j.jemermed.2011.05.072
Article
PubMed
PubMed Central
Google Scholar
Ugarte H, Silva E, Mercan D, De Mendonça A, Vincent JL: Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999, 27: 498-504. 10.1097/00003246-199903000-00024
Article
PubMed
CAS
Google Scholar
Terradas R, Grau S, Blanch J, Riu M, Saballs P, Castells X, Horcajada JP, Knobel H: Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort study. PLoS One 2012, 7: e42860. 10.1371/journal.pone.0042860
Article
PubMed
CAS
PubMed Central
Google Scholar
Ho KM, Towler SC: A comparison of eosinopenia and C-reactive protein as a marker of bloodstream infections in critically ill patients: a case control study. Anaesth Intensive Care 2009, 37: 450-456.
PubMed
CAS
Google Scholar
Moreira VG, Prieto B, Rodríguez JSM, Alvarez FV: Usefulness of cell-free plasma DNA, procalcitonin and C-reactive protein as markers of infection in febrile patients. Ann Clin Biochem 2010, 47: 253-258. 10.1258/acb.2010.009173
Article
PubMed
CAS
Google Scholar
Saukkonen K, Lakkisto P, Pettilä V, Varpula M, Karlsson S, Ruokonen E, Pulkki K, Finnsepsis Study Group: Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock. Clin Chem 2008, 54: 1000-1007. 10.1373/clinchem.2007.101030
Article
PubMed
CAS
Google Scholar
Dwivedi DJ, Toltl LJ, Swystun LL, Pogue J, Liaw K-L, Weitz JI, Cook DJ, Fox-Robichaud AE, Liaw PC, Canadian Critical Care Translational Biology Group: Prognostic utility and characterization of cell-free DNA in patients with severe sepsis. Crit Care 2012, 16: R151. 10.1186/cc11466
Article
PubMed
PubMed Central
Google Scholar
Kung C-T, Hsiao S-Y, Tsai T-C, Su C-M, Chang W-N, Huang C-R, Wang H-C, Lin W-C, Chang H-W, Lin Y-J, Cheng B-C, Su BY-J, Tsai N-W, Lu C-H: Plasma nuclear and mitochondrial DNA levels as predictors of outcome in severe sepsis patients in the emergency room. J Transl Med 2012, 10: 130. 10.1186/1479-5876-10-130
Article
PubMed
CAS
PubMed Central
Google Scholar
Su Y-H, Wang M, Block TM, Landt O, Botezatu I, Serdyuk O, Lichtenstein A, Melkonyan H, Tomei LD, Umansky S: Transrenal DNA as a diagnostic tool: important technical notes. Ann N Y Acad Sci 2004, 1022: 81-89. 10.1196/annals.1318.014
Article
PubMed
CAS
Google Scholar
Brodská H, Malíčková K, Adámková V, Benáková H, Šťastná MM, Zima T: Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis. Clin Exp Med 2013, 13: 165-170. 10.1007/s10238-012-0191-8
Article
PubMed
Google Scholar
Jung M, Klotzek S, Lewandowski M, Fleischhacker M, Jung K: Changes in concentration of DNA in serum and plasma during storage of blood samples. Clin Chem 2003, 49: 1028-1029. 10.1373/49.6.1028
Article
PubMed
CAS
Google Scholar
Pathak AK, Bhutani M, Kumar S, Mohan A, Guleria R: Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. Clin Chem 2006, 52: 1833-1842.
PubMed
CAS
Google Scholar
Umetani N, Hiramatsu S, Hoon DSB: Higher amount of free circulating DNA in serum than in plasma is not mainly caused by contaminated extraneous DNA during separation. Ann N Y Acad Sci 2006, 1075: 299-307. 10.1196/annals.1368.040
Article
PubMed
CAS
Google Scholar